<DOC>
<DOCNO>
EP-0000089
</DOCNO>
<TEXT>
<DATE>
19781220
</DATE>
<IPC-CLASSIFICATIONS>
C07D-233/00 C07D-233/44 A61P-21/00 A61P-21/02 C07D-233/48 A61K-31/415 
</IPC-CLASSIFICATIONS>
<TITLE>
imidazole-2-carbamates and process for their production and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
syntex incus<sep>syntex (u.s.a.) inc.<sep>syntex (u.s.a.) inc.3401 hillview avenuepalo alto california 94303us<sep>
</APPLICANT>
<INVENTOR>
beard colin cus <sep>wallach marshall bus   <sep>weinhardt klaus kus<sep>beard, colin c.<sep>wallach, marshall b.<sep>weinhardt, klaus k.<sep>beard, colin c.578 jefferson avenuepalo alto, california 94304us<sep>wallach, marshall b.2704 katrina waymt. view, california 94040us<sep>weinhardt, klaus k.616 canyon roadredwood city, california 94062us<sep>
</INVENTOR>
<ABSTRACT>
imidazole-2-carbamates represented by the formula    wherein r is hydrogen or alkyl of 1-4 carbons, rยน is alkyl of  1-6 carbons and the naphthyl group is attached to the  imidazole ring at the 1 or 2 positions of the naphthyl ring, and  the pharmaceutically acceptable salts thereof.  these compounds are useful as centrally acting skeletal  muscle relaxants.  the compounds are prepared by ring closure of a compound  of the formula  
</ABSTRACT>
</TEXT>
</DOC>
